BIOSTAR PHARMACEUTICALS, INC.
ARTICLES OF AMENDMENT
Biostar Pharmaceuticals, Inc., a Maryland corporation having its principal office in Cockeysville, Maryland
(hereinafter called the "corporation"), hereby certifies to the State Department of Assessments and Taxation of
FIRST: The Articles of Incorporation of the corporation dated March 23, 2007 are hereby amended by striking
out Article SIXTH of the Articles of Incorporation and inserting in lieu thereof the following:
Section (1). Authorized Shares of Capital Stock
(a) Authorized Shares. The total number of shares of stock of all classes which the corporation has authority to
issue is one hundred and ten million (110,000,000) shares of capital stock, of which (i) 100,000,000 shares shall
be designated common stock, $0.001 par value per share, and of the aggregate par value of One Hundred
Thousand Dollars ($100,000) ("Common Stock"), (ii) 5,000,000 shares shall be designated Series A
Convertible Preferred Stock, $0.001 par value and of the aggregate par value of Five Thousand Dollars
($5,000) ("Series A Preferred") and (iii) 5,000,000 shares shall be designated Blank Check Preferred Stock,
$0.001 par value per share and of the aggregate par value of Five Thousand Dollars ($5,000) ("Blank Check
Preferred Stock"), which Blank Check Preferred Stock may be issued in one or more classes or series as
described in Section (3) hereof. The Common Stock, the Series A Preferred and each class or series of Blank
Check Preferred Stock shall each constitute a separate class of stock of the Corporation.
The Board of Directors of the corporation (the "Board of Directors") may classify and reclassify any unissued
shares of Capital Stock (as defined below) in accordance with Section (4) hereof.
The Common Stock, the Series A Preferred and the Blank Check Preferred Stock are collectively referred to
herein as "Capital Stock." The aggregate par value of all the corporation's authorized Capital Stock having par
value is $110,00